SMYD1 and cardiomyopathy: This SMYD1 variant is currently classified as a “variant of uncertain significance (VUS)”, because it is a novel missense variant with no previous association to human disease or specific functional studies to this variant before this report, although there is strong evidence in animal models linking perturbations in SMYD1 to cardiomyopathies.